Zenas BioPharma CEO Leon Moulder Purchases 60,000 Shares for $1.01 Million
Leon Moulder, CEO of Zenas BioPharma (ZBIO), acquired 60,000 shares for $1.01 million on May 18, 2026. The transaction represents 13.04% of his aggregate holdings prior to the purchase.
Leon Moulder, chief executive officer of Zenas BioPharma (ZBIO), purchased 60,000 shares of the biotechnology company on May 18, 2026, for approximately $1.01 million. The transaction implies a per-share price of roughly $16.83.
The acquisition increased Moulder's holdings by 13.04% relative to his position immediately before the purchase, bringing his aggregate stake to approximately 520,000 shares. The purchase represents a material commitment of capital by the company's top executive to equity in the clinical-stage biopharma.
Continue reading
3 more paragraphs for subscribers.
Free readers get a daily preview and the weekly long-form. Premium unlocks every brief in full, AM & PM editions, alerts, and the archive.